Clinical application of Azithromycin in treating pediatric Mycoplasma Pneumonia and its effects on platelet count, D-Dimer Levels, and Serum Inflammatory Factors
Azithromycin offers multiple benefits in treating pediatric mycoplasma pneumonia, including rapid symptom resolution, potent anti-inflammatory effects, regulation of coagulation-fibrinolysis balance, reduction in serum inflammatory factor levels, and a lower incidence of adverse reactions.
Authors
- Songjian Lu (ORCID: https://orcid.org/0000-0002-6976-9294)
- Honghua Lin
- Kun Dong (ORCID: https://orcid.org/0000-0003-3204-078X)
- Wenjuan Tong
Institutions
- Anhui Provincial Children's Hospital (CN)
Publication Details
- Journal
- Pakistan Journal of Medical Sciences
- Published
- 2025-11-25
- DOI
- https://doi.org/10.12669/pjms.41.12.12489
- Primary Topic
- Pneumonia and Respiratory Infections
- Type
- article
- Field-Weighted Citation Impact
- 0.00